There are two main types of congenital heart disease: acyanotic and cyanotic. Acyanotic congenital heart disease, in which ...

Where this device will fit in with other emerging options remains to be seen, but it might hold an advantage in large annuli.

Edwards stock shot higher Thursday after the medtech player said tariffs are likely to have little impact in 2025.

On July 11, 2024, Affluent Medical reached a major milestone with the signature of several agreements with Edwards Lifesciences, a global MedTech player, recognizing the relevance and potential of the ...

"The ultimate goal, which we've achieved to some degree," New Orleans doctor, Craig Sable, said. "Is to teach the locals and build the infrastructure to teach the local team how to do heart surgery on ...

A St. Louis-based company has added to its holdings in the environmental monitoring sector with the addition of a California company.

Edwards Lifesciences raised its 2025 sales forecast on Wednesday after a quarterly beat, driven by robust demand for its artificial heart valves and other medical equipment.

The BluePearl Pet Hospital in Tampa, Florida, is now offering the transcatheter edge-to-edge repair (TEER) procedure for its ...

This week’s Bulls N’ Bears ASX Runner of the Week is… Redstone Resources, which announced a biblically deep drill hole to ...

Valve failure on barge causes vapor cloud; no injuries or air quality threats reported, Houston Ship Channel reopens.

Dapagliflozin reduced the risk of death or worsening heart failure in older patients with aortic stenosis who underwent transcatheter aortic-valve implantation.

IRVINE, CA / ACCESS Newswire / April 23, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno" or the "Company"), a ...